Amicar and hyperfibrinolysis.
D000614:Aminocaproates / Q000009:adverse effects / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D004438:Ecchymosis; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006417:Hematuria / Q000188:drug therapy*; D006470:Hemorrhage / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011471:Prostatic Neoplasms / Q000188:drug therapy
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D006493:Heparin